Divisions of Human Genetics and.
Ophthalmology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; the.
Retin Cases Brief Rep. 2022 May 1;16(3):385-392. doi: 10.1097/ICB.0000000000000992. Epub 2020 Mar 4.
To describe in detail the phenotype of two siblings with biallelic NMNAT1 mutations.
A 4-year-old male patient (P1) and his 7-year-old sister (P2), product of a nonconsanguineous union of Egyptian ancestry, underwent a comprehensive ophthalmic examination, retinal imaging with spectral domain optical coherence tomography and near infrared (NIR) fundus autofluorescence (FAF), and full-field electroretinograms (ERG).
Patients had blurred vision and nystagmus at ∼3 years of age. P2 was hyperopic (+6D). Visual acuity in P1 was 20/100 at age 3 and remained at ∼20/125 at age 4; P2 visual acuity was 20/70 at age 4 and declined to ∼20/200 at age 7. ERGs recorded in P1 showed relatively large rod-mediated responses but nearly undetectable cone signals. There was foveal/parafoveal depigmentation. Spectral domain optical coherence tomography showed hypoplastic foveas, a thin outer nuclear layer centrally but normal thickness beyond the vascular arcades. At the foveal center, cone outer segments were absent and the outer nuclear layer was further hyporreflective. The inner retina was mostly within normal limits. There was central depigmentation on near infrared fundus autofluorescence. Biallelic mutations were identified in NMNAT1: One was previously reported (c.769 G>A; pGlu257Lys), and the other one (c.245T>C; pVal82Ala) was novel.
NMNAT1 mutations cause a consistent phenotype characterized by early-onset, progressive, cone>rod retinawide dysfunction and predominantly central abnormalities ranging from a hypoplastic to an atrophic fovea, supporting a critical role for NMNAT1 in central retinal development and maintenance. Relatively preserved inner retina and detectable photoreceptors may become therapeutic targets.
详细描述 2 名具有双等位基因 NMNAT1 突变的同胞的表型。
对一名 4 岁男性患者(P1)和他 7 岁的妹妹(P2)进行了全面的眼科检查,包括眼底成像的频域光相干断层扫描和近红外(NIR)眼底自发荧光(FAF),以及全视野视网膜电图(ERG)。
患者在 3 岁时出现视力模糊和眼球震颤。P2 远视(+6D)。P1 在 3 岁时的视力为 20/100,4 岁时保持在 20/125;P2 在 4 岁时的视力为 20/70,在 7 岁时降至 20/200。P1 的 ERG 记录显示相对较大的杆状介导反应,但几乎无法检测到锥状信号。存在中心凹/旁中心凹脱色素。频域光相干断层扫描显示中心凹发育不良,中央的外核层变薄,但血管弓以外的厚度正常。在中心凹处,锥体细胞外节缺失,外核层进一步低反射。内层视网膜大多在正常范围内。NIR 眼底自发荧光上存在中心脱色素。在 NMNAT1 中发现了双等位基因突变:一个是先前报道的(c.769 G>A;pGlu257Lys),另一个是新发现的(c.245T>C;pVal82Ala)。
NMNAT1 突变导致一致的表型,其特征为早发性、进行性、锥体细胞>杆体细胞广泛的视网膜功能障碍,主要为从发育不良到萎缩的中央异常,包括从发育不良到萎缩的中心凹,支持 NMNAT1 在中央视网膜发育和维持中的关键作用。相对保留的内层视网膜和可检测的光感受器可能成为治疗靶点。